Diagnostic accuracy of palpation versus ultrasound-guided fine needle aspiration biopsy for diagnosis of malignancy in thyroid nodules: a systematic review and meta-analysis

Tarigan, Tri Juli Edi; Anwar, Budiman Syaeful; Sinto, Robert; Wisnu, Wismandari

doi:10.1186/s12902-022-01085-5

Table 4 The characteristics of the studies

From: Diagnostic accuracy of palpation versus ultrasound-guided fine needle aspiration biopsy for diagnosis of malignancy in thyroid nodules: a systematic review and meta-analysis

No ID	First author (Publication year)	Country	Research Design	Technique	Subject age (Mean/median [year])	Sample size	Inadequate/ Non-diagnostic	benign	AUS, FLUS, FN (Indeterminant)	Malignancy suspicion, malignancy (Malignant)
1	Takashima et al. (1994) [9]	Japan	Cross Section	PGFNAB	53	34	0	12	0	22
1	Takashima et al. (1994) [9]	Japan	Cross Section	USGFNAB	53	99	0	32	0	67
2	Hatada et al. (1998) [11]	Japan	Cross Section	PGFNAB	54.7 ± 13.7	94	28	42	0	24
2	Hatada et al. (1998) [11]	Japan	Cross Section	USGFNAB	51.4 ± 16	72	12	37	0	23
3	Danese et al. (1998) [10]	Italy	Cross Section	PGFNAB	43	535	13	307	160	55
3	Danese et al. (1998) [10]	Italy	Cross Section	USGFNAB	43	540	5	310	155	70
4	Carmeci et al. (1998) [12]	US	Cross Section	PGFNAB	49.2	47	6	13	7	21
4	Carmeci et al. (1998) [12]	US	Cross Section	USGFNAB	49.2	17	2	1	4	10
5	Solymosi et al. (2001) [23]	Hungary	Cross Section	PGFNAB	N/A	354	37	197	0	120
5	Solymosi et al. (2001) [23]	Hungary	Cross Section	USGFNAB	N/A	420	40	302	0	78
6	Goudy et al. (2005) [13]	US	Cross Section	PGFNAB	55.4	20	2	12	2	4
6	Goudy et al. (2005) [13]	US	Cross Section	USGFNAB	55.4	11	0	4	6	1
7	Cesur et al. (2006) [14]	Turkey	Cross Section	PGFNAB	48.7 ± 13.5	26	8	11	3	4
7	Cesur et al. (2006) [14]	Turkey	Cross Section	USGFNAB	48.7 ± 13.5	26	4	14	4	4
8	Izquierdo et al. (2006) [15]	US	Perspective Cohort	PGFNAB	48.6 ± 17	23	0	11	5	7
8	Izquierdo et al. (2006) [15]	US	Perspective Cohort	USGFNAB		5	0	1	3	1
9	Can et al. (2008) [16]	Turkey	Cross Section	PGFNAB	40 ± 12	18	3	12	1	2
9	Can et al. (2008) [16]	Turkey	Cross Section	USGFNAB	44 ± 14	23	1	11	6	5
10	Krishnappa et al. (2013) [17]	India	Cross Section	PGFNAB	38.5	25	0	15	0	10
10	Krishnappa et al. (2013) [17]	India	Cross Section	USGFNAB		25	0	15	0	10
11	Guo et al. (2015) [18]	China	Cross Section	PGFNAB	44	101	2	–	27	72
11	Guo et al. (2015) [18]	China	Cross Section	USGFNAB		388	8	–	57	323
12	Sharma et al. (2017) [19]	India	Cross Section	PGFNAB	36.4	49	0	38	7	4
12	Sharma et al. (2017) [19]	India	Cross Section	USGFNAB	36	80	0	74	3	3
13	Choong et al. (2018) [7]	US	Cross Section	PGFNAB	51.5	1199	60	725	285	129
13	Choong et al. (2018) [7]	US	Cross Section	USGFNAB	53.6	1123	50	639	286	148
14	Taha et al. (2020) [5]	Qatar	Cross Section	PGFNAB	46.3 ± 11.7	570	98	398	52	140
14	Taha et al. (2020) [5]	Qatar	Cross Section	USGFNAB		392	51	215	58	146

Penjelasan dari AUS, FLUS, FN

Back to article page

ISSN: 1472-6823

Contact us

General enquiries: journalsubmissions@springernature.com

BMC Endocrine Disorders

Contact us